40 results
8-K
VERV
Verve Therapeutics Inc
2 Apr 24
Other Events
7:13am
Heart-1 trial, including the Company’s assessment of the laboratory abnormalities observed in the trial and the Company’s interactions with regulatory
424B5
VERV
Verve Therapeutics Inc
29 Nov 23
Prospectus supplement for primary offering
4:47pm
entity thereof under any law, statute or constitutional provision or by the enforcement of any assessment or by any legal or equitable proceeding … are fully paid and not liable to further calls or assessment by us. The rights, preferences and privileges of holders of our common stock are subject
424B5
VERV
Verve Therapeutics Inc
28 Nov 23
Prospectus supplement for primary offering
4:25pm
thereof under any law, statute or constitutional provision or by the enforcement of any assessment or by any legal or equitable proceeding or otherwise … are fully paid and not liable to further calls or assessment by us. The rights, preferences and privileges of holders of our common stock are subject
S-3ASR
EX-4.4
dr9mqof 0s66kfxc
23 Sep 22
Automatic shelf registration
4:08pm
S-3ASR
6r7b6 ydh
23 Sep 22
Automatic shelf registration
4:08pm
S-3ASR
EX-4.5
yxvsd
23 Sep 22
Automatic shelf registration
4:08pm
424B5
pxw5xjskbgdwcynbk
21 Jul 22
Prospectus supplement for primary offering
4:43pm
424B5
0o0k894
20 Jul 22
Prospectus supplement for primary offering
4:22pm
S-3
yo6gd
1 Jul 22
Shelf registration
4:36pm